Metastatic spread to bone: The role of chemotherapy

Stefano Ferrari, Emanuela Palmerini, Andreas F. Mavrogenis, Pietro Ruggieri

Research output: Chapter in Book/Report/Conference proceedingChapter


Genetic profiling of tumors has revealed important regulators of the metastatic process and suggested novel targets for cancer therapeutics. Targeting the tumor cell alone is not sufficient; multimodality therapy against tumor cells, their growth factors and the essential accessory cells with which cancer cells interact is imperative. In the bone marrow and within the tumor stroma, two niches constitute highly specific, physiologically defined sites; the vascular and stromal niche. A high preponderance of tumor cells is found in the bone marrow of patients with malignancy, even in the absence of overt distant metastases. Bisphosphonates inhibit normal and pathologic osteoclast-mediated bone resorption. Denosumab inhibits the maturation of osteoclasts by binding to RANKL, protecting the bone from degradation.

Original languageEnglish
Title of host publicationAdvances in Bone Metastasis Management
PublisherFuture Medicine Ltd.
Number of pages10
ISBN (Print)9781780840307, 9781780841151
Publication statusPublished - Mar 1 2012

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Metastatic spread to bone: The role of chemotherapy'. Together they form a unique fingerprint.

Cite this